CES HK Biotechnology Index (CES HK Biotech) is a price return index provides a measure of market performance for biotechnology companies listed on the Stock Exchange of Hong Kong Limited (SEHK).
| Product Name | Product Type |
|---|
| Index Name | No. of Constituents |
|---|---|
| CSI 300 | 300 |
| SSE 50 | 50 |
| CSI 500 | 500 |
| SSE Index | 1493 |
As of:2020-08-07
| Close | Change(%) | Turnover (100 Million Yuan) | 1 Mo Returns(%) |
|---|---|---|---|
| 9914.49 | -2.42 | 35.78 |
As of:2020-08-07
| Code | Name | Sector | Weight(%) |
|---|---|---|---|
| 2269 | WUXI BIOLOGICS (CAYMAN) INC. | Health Care | 17.31 |
| 1801 | Innovent Biologics, Inc. | Health Care | 13.70 |
| 1177 | Sino Biopharm | Health Care | 13.44 |
| 2359 | WUXI APPTEC CO., LTD. | Health Care | 11.29 |
| 6185 | CanSino Biologics Inc. | Health Care | 7.52 |
| 1548 | Genscript Biotech Corporation | Health Care | 6.10 |
| 1530 | 3SBIO INC. | Health Care | 5.49 |
| 1873 | VIVA BIOTECH HOLDINGS | Health Care | 4.53 |
| 2500 | Venus Medtech (Hangzhou) Inc. | Health Care | 4.40 |
| 3759 | Pharmaron Beijing Co., Ltd. | Health Care | 4.31 |
沪公网安备 31011502008255号
CSI Indices
CSI Valuation
CSI Ratings
